Farmed Salmon Genetics and Welfare Trade-offs

Selective breeding has dramatically increased salmon growth rates but created welfare concerns around physiology and behaviour. Understanding these trade-offs is essential for responsible aquaculture.

Key Facts

Farmed Atlantic salmon grow approximately 5-6 times faster than wild salmon due to decades of selective breeding
Rapid growth creates skeletal deformities in up to 10% of some commercial strains, causing pain and reduced mobility
Heart and skeletal muscle inflammation (HSMI) and cardiomyopathy syndrome (CMS) are increasingly common in fast-growing strains
Spinal deformities including vertebral compression are more prevalent in faster-growing genetic lines
Smoltification timing can be disrupted in some breeds, causing chronic physiological stress
CRISPR and traditional breeding are being explored to decouple growth rate from welfare-compromising traits

Welfare Considerations

The genetics-welfare trade-off in farmed salmon represents one of the clearest examples of how commercial pressure can compromise animal wellbeing at the biological level. When selective breeding prioritises growth rate without simultaneously selecting against welfare-compromising traits, animals may be predisposed to suffering by their own genetics. The solution lies in integrated selection programmes that treat welfare as a breeding objective equal to production traits. Some Norwegian breeding companies have made progress on this approach, demonstrating that it is commercially viable.

What You Can Do

Support aquaculture producers that publish welfare metrics including deformity and disease rates
Advocate for welfare traits to be mandatory selection criteria in aquaculture breeding programmes
Choose certified salmon products where welfare auditing is independent and rigorous
Support research into salmon genetics that prioritises welfare alongside production traits
Reduce salmon consumption or choose alternative protein sources if welfare-certified options are unavailable